BCG for Therapeutic Use Phase I Clinical Trial

Clinical trial NCT06100653 · COMPLETED

Trial details

NCT number: NCT06100653
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-muscular Invasive Bladder Cancer

Start date: 2023-11-22
Primary completion: 2025-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.